Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2181

Actual shortage: 187 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 8 (0%)
Resolved: 1986 (91%)

Discontinuation Reports

349

To be discontinued: 20 (6%)
Discontinued: 329 (94%)
Reversed: 0 (0%)

Late reports

130 (5%)

Overdue reports

20 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95871
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95874
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2020-01-15 2020-02-01 103370
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2020-05-13 2020-05-15 114944
APO-DICLO 50MG TABLET (ENTERIC-COATED) Resolved 2020-08-06 2020-09-28 121894
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2020-09-09 2020-10-26 123921
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2020-09-17 2020-09-25 124347
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2021-01-26 125806
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2020-12-29 125809
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2020-12-04 2021-06-14 129608
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2020-12-18 2021-01-19 130410
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2021-01-08 2021-01-12 131154
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2021-02-26 2021-03-19 134823
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2021-03-26 2021-04-12 136409
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2021-05-07 2021-06-14 138966
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-06-04 2021-06-14 140423
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2021-06-11 2021-07-26 140777
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2021-06-18 2021-07-26 141247
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-09-24 2021-10-05 146157
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2021-10-01 2021-10-01 146511

Showing 1981 to 2000 of 2181

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-09-07 2018-09-15 60241
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-12-21 2018-12-24 70347
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029

Showing 1 to 20 of 349